drugset / Trial / NCT01882062

Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease

NCT01882062

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this project is to study the efficacy of an anaplerotic treatment on brain energy profile evolution at an early stage of the Huntington disease.

Timeline

Start
2013-05
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Triheptanoin Other / unclassified 1 g/kg

Indications